Abstract
Glutathione S-transferase P1-1 (GSTP1-1) conjugates glutathione to electrophilic compounds and its expression is correlated to chemotherapeutic drug resistance. Results show that GSTP1-1 mRNA as well as protein expressions are increased during Aclarubicin (Acla)- and Doxorubicin (Dox)-induced erythroid differentiation of human K562 cells. In contrast, during megakaryocytic differentiation by 12-O-tetradecanoyl phorbol 13-acetate (TPA), GSTP1-1 expression decreased at both mRNA and protein levels. In order to clarify the molecular mechanisms leading to these variations, we identified a GATA sequence located at -1208 relative to the transcriptional start site of the GSTP1-1 promoter. By gel shift, competition, and supershift analyses we show here the specificity of the GATA-1 binding regulated by both anthracyclines and TPA. Altogether, these results demonstrate for the first time the implication of GATA-1 in differentiation-specific variations of GSTP1-1 expression.
Original language | English |
---|---|
Pages (from-to) | 815-821 |
Number of pages | 7 |
Journal | Biochemical and Biophysical Research Communications |
Volume | 311 |
Issue number | 4 |
DOIs | |
Publication status | Published - 28 Nov 2003 |
Externally published | Yes |
Keywords
- Aclarubicin
- Doxorubicin
- Erythroid and megakaryocytic differentiation
- GATA-1
- GSTP1-1
- K562
- TPA